Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Waters Corporation (WAT)

325.4   -8.33 (-2.5%) 01-19 09:33
Open: 327.14 Pre. Close: 333.73
High: 327.79 Low: 323.45
Volume: 299,583 Market Cap: 19,861M
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 328.554 - 330.73 330.73 - 332.697
Low: 317.993 - 320.809 320.809 - 323.353
Close: 321.105 - 325.485 325.485 - 329.445

Technical analysis

as of: 2022-01-19 9:25:13 AM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 415.17     One year: 438.28
Support: Support1: 323.45    Support2: 269.11
Resistance: Resistance1: 355.46    Resistance2: 375.24
Pivot: 349.50
Moving Average: MA(5): 333.26     MA(20): 352.49
MA(100): 361.03     MA(250): 338.17
MACD: MACD(12,26): -5.47     Signal(9): -1.45
Stochastic oscillator: %K(14,3): 5.57     %D(3): 10.92
RSI: RSI(14): 28.00
52-week: High: 428.22  Low: 258.91  Change(%): 19.0
Average Vol(K): 3-Month: 37461  10-Days: 42775

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
WAT has closed above bottom band by 10.0%. Bollinger Bands are 59.6% wider than normal. The large width of the bands suggest high volatility as compared to WAT's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Wed, 19 Jan 2022
Should You Think About Buying Waters Corporation (NYSE:WAT) Now? - Simply Wall St

Sun, 16 Jan 2022
Waters Corporation - Consensus Indicates Potential 6.6% Upside - DirectorsTalk Interviews

Wed, 12 Jan 2022
Waters Corporation Q4 2021 Financial Results Webcast Invitation - Business Wire

Wed, 12 Jan 2022
Waters Accelerates Quantitative Mass Spectrometry With New Application on waters_connect Informatics Platform - Business Wire

Mon, 10 Jan 2022
Waters To Present At J.P. Morgan Healthcare Conference; Webcast At 8:15 AM ET - Nasdaq

Mon, 10 Jan 2022
Brokers Offer Predictions for Waters Co.'s FY2023 Earnings (NYSE:WAT) - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 61
Shares Float (M) 61
% Held by Insiders 0.62
% Held by Institutions 91.28
Shares Short (K) 1,940
Shares Short P. Month (K) 1,860

Stock Financials

EPS 11.160
EPS Est This Year 7.400
EPS Est Next Year 8.040
Book Value (p.s.) 4.830
Profit Margin 25.40
Operating Margin 30.33
Return on Assets (ttm) 17.9
Return on Equity (ttm) 548.0
Qtrly Rev. Growth 11.0
Gross Profit (p.s.) 22.280
Sales Per Share 44.889
EBITDA (p.s.) 15.760
Qtrly Earnings Growth 27.10
Operating Cash Flow (M) 797
Levered Free Cash Flow (M) 474

Stock Valuations

PE Ratio 29.16
PEG Ratio
Price to Book value 67.37
Price to Sales 7.25
Price to Cash Flow 24.93

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1996-11-25
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.